Dr. Sandler brings more than 30 years of experience as a distinguished leader in oncology and drug developmentSOUTH SAN ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Botensilimab is a human Fc enhanced CTLA-4 blocking antibody designed to boost both innate and adaptive anti-tumor ... Agenus is a leading immuno-oncology company targeting cancer with a comprehensive ...

Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...

In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where the 7th China International ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ... T cell engagers (TCE) are a powerful class of ...

We expect retailers to focus on hyper-personalization to drive a more conversational customer experience and boost sales." About Infobip Infobip ... Agenus Inc. ("Agenus" or the "Company") , an immuno ...

There are four main wellness programmes on offer: Complete Life Rewind, Optimal Weight, Deep Detox and Immuno Boost. Each is designed to be undertaken over a minimum of seven days and incorporate ...